Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

How I treat disseminated intravascular coagulation

Marcel Levi, Marie Scully

Blood (2018) 131 (8): 845–854.

https://doi.org/10.1182/blood-2017-10-804096

Published: 2018

Journal Articles

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

Ida Martinelli, Anthonie W. A. Lensing, Saskia Middeldorp, Marcel Levi, Jan Beyer-Westendorf, Bonno van Bellen, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Mila Trajanovic, Martin Gebel, Phuong Lam, Philip S. Wells, Martin H. Prins

Blood (2016) 127 (11): 1417–1425.

https://doi.org/10.1182/blood-2015-08-665927

Published: 2016

Journal Articles

The dual face of heparin in severe infection

Marcel Levi

Blood (2014) 123 (7): 947–948.

https://doi.org/10.1182/blood-2013-12-541250

Published: 2014

Journal Articles

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

Hong Zhang, Ester C. Löwenberg, Jeffrey R. Crosby, A. Robert MacLeod, Chenguang Zhao, Dacao Gao, Chris Black, Alexey S. Revenko, Joost C. M. Meijers, Erik S. Stroes, Marcel Levi, Brett P. Monia

Blood (2010) 116 (22): 4684–4692.

https://doi.org/10.1182/blood-2010-04-277798

Published: 2010

Includes: Multimedia, Supplemental data

Journal Articles

Prothrombin Complex Concentrate Reverses the Anticoagulant Effect of Rivaroxaban In Healthy Volunteers.

Elise S Eerenberg, MD, Meertien K Sijpkens, BSc, Pieter W Kamphuisen, MD, Joost CM Meijers, PhD, Marcel Levi, MD

Blood (2010) 116 (21): 1094.

https://doi.org/10.1182/blood.V116.21.1094.1094

Published: 2010

Journal Articles

Combination of FXI Antisense Oligonucleotide and Plavix® Treatment Results in Enhanced Antithrombotic Activity without Increased Risk of Bleeding in Mouse Models of Thrombosis.

Dacao Gao, Jeff Crosby, PhD, Robert MacLeod, PhD, Gourab Bhattacharjee, PhD, Ester C Lowenberg, MD, Marcel Levi, MD, PhD, Prof., Brett P. Monia, PhD

Blood (2009) 114 (22): 4173.

https://doi.org/10.1182/blood.V114.22.4173.4173

Published: 2009

Journal Articles

Pharmacological Characterization and Structure Activity Relationship of FXI Antisense Oligonucleotides in Cynomolgus Monkeys.

Robert MacLeod, PhD, Jeff Crosby, PhD, Chenguang Zhao, Dacao Gao, Chris May, Hong Zhang, MD, Ester C Lowenberg, MD, Marcel Levi, Prof. MD, PhD, Brett P. Monia, PhD

Blood (2009) 114 (22): 2101.

https://doi.org/10.1182/blood.V114.22.2101.2101

Published: 2009

Journal Articles

Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Ester C Lowenberg, MD, Sophie Cohen, Bert-Jan H van den Born, MD, PhD, J.C.M. Meijers, PhD, Marcel Levi, MD, PhD, Arjen M Dondorp, MD, PhD

Blood (2008) 112 (11): 3912.

https://doi.org/10.1182/blood.V112.11.3912.3912

Published: 2008

Journal Articles

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

Michiel E. Stegenga, Saskia N. van der Crabben, Regje M. E. Blümer, Marcel Levi, Joost C. M. Meijers, Mireille J. Serlie, Michael W. T. Tanck, Hans P. Sauerwein, Tom van der Poll

Blood (2008) 112 (1): 82–89.

https://doi.org/10.1182/blood-2007-11-121723

Published: 2008

Journal Articles

Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based

Marcel Levi, G. Kees Hovingh, Suzanne C. Cannegieter, Marinus Vermeulen, Harry R. Büller, Frits R. Rosendaal

Blood (2008) 111 (9): 4471–4476.

https://doi.org/10.1182/blood-2007-11-123711

Published: 2008

Journal Articles

Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes

Blood (2008) 111 (8): 4096–4105.

https://doi.org/10.1182/blood-2007-05-089565

Published: 2008

Includes: Supplemental data

Journal Articles

Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia

Rosemarijn Renckens, Joris J. T. H. Roelofs, Peter I. Bonta, Sandrine Florquin, Carlie J. M. de Vries, Marcel Levi, Peter Carmeliet, Cornelis van't Veer, Tom van der Poll

Blood (2006) 109 (4): 1593–1601.

https://doi.org/10.1182/blood-2006-05-025197

Published: 2006

Journal Articles

A Reduced Capacity To Generate Activated Protein C and the Role of PAI-1 Deficiency on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia.

Tymen Keller, Matthijs van Wissen, Koen van der Sluijs, PhD, Eric van Gorp, PhD, Joost Meijers, PhD, Tom van der Poll, PhD, Harry Buller, PhD, Dees Brandjes, PhD, Marcel Levi, PhD, Victor Gerdes, PhD

Blood (2005) 106 (11): 2134.

https://doi.org/10.1182/blood.V106.11.2134.2134

Published: 2005

Journal Articles

Cell surface–targeted anticoagulation in systemic infection and inflammation

Marcel Levi

Blood (2004) 104 (5): 1231–1232.

https://doi.org/10.1182/blood-2004-06-2255

Published: 2004

Journal Articles

Superactive analogs of factor VIIa: superglue for bleeding patients?

Marcel Levi

Blood (2003) 102 (10): 3466.

https://doi.org/10.1182/blood-2003-08-2988

Published: 2003

Journal Articles

Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumonia

Anita W. Rijneveld, Sandrine Florquin, Paul Bresser, Marcel Levi, Vivian de Waard, Roger Lijnen, Jaring S. Van der Zee, Peter Speelman, Peter Carmeliet, Tom van der Poll

Blood (2003) 102 (3): 934–939.

https://doi.org/10.1182/blood-2003-01-0227

Published: 2003

Journal Articles

Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C–deficient mice

Marcel Levi, Janine Dörffler-Melly, Pieter Reitsma, Harry Büller, Sandrine Florquin, Tom van der Poll, Peter Carmeliet

Blood (2003) 101 (12): 4823–4827.

https://doi.org/10.1182/blood-2002-10-3254

Published: 2003

Journal Articles

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia

Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey, C. Erik Hack, Susan K. Paulson, Aziz Karim, Jozef Kesecioglu, Marcel Levi, Sander J. H. van Deventer, Tom van der Poll

Blood (2000) 95 (4): 1124–1129.

https://doi.org/10.1182/blood.V95.4.1124.002k20_1124_1129

Published: 2000

Journal Articles

Effect of a Recombinant Dimeric Tumor Necrosis Factor Receptor on Inflammatory Responses to Intravenous Endotoxin in Normal Humans

Tom van der Poll, Susette M. Coyle, Marcel Levi, Patty M. Jansen, Mieke Dentener, Karen Barbosa, Wim A. Buurman, C. Erik Hack, Jan W. ten Cate, Jan M. Agosti, Stephen F. Lowry

Blood (1997) 89 (10): 3727–3734.

https://doi.org/10.1182/blood.V89.10.3727

Published: 1997

Journal Articles

Interleukin-10 Inhibits Activation of Coagulation and Fibrinolysis During Human Endotoxemia

Dasja Pajkrt, Tom van der Poll, Marcel Levi, David L. Cutler, Melton B. Affrime, Abraham van den Ende, Jan Wouter ten Cate, Sander J.H. van Deventer

Blood (1997) 89 (8): 2701–2705.

https://doi.org/10.1182/blood.V89.8.2701

Published: 1997

NARROW

How I treat disseminated intravascular coagulation

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

The dual face of heparin in severe infection

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

Prothrombin Complex Concentrate Reverses the Anticoagulant Effect of Rivaroxaban In Healthy Volunteers.

Combination of FXI Antisense Oligonucleotide and Plavix® Treatment Results in Enhanced Antithrombotic Activity without Increased Risk of Bleeding in Mouse Models of Thrombosis.

Pharmacological Characterization and Structure Activity Relationship of FXI Antisense Oligonucleotides in Cynomolgus Monkeys.

Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based

Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes

Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia

A Reduced Capacity To Generate Activated Protein C and the Role of PAI-1 Deficiency on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia.

Cell surface–targeted anticoagulation in systemic infection and inflammation

Superactive analogs of factor VIIa: superglue for bleeding patients?

Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumonia

Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C–deficient mice

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia

Effect of a Recombinant Dimeric Tumor Necrosis Factor Receptor on Inflammatory Responses to Intravenous Endotoxin in Normal Humans

Interleukin-10 Inhibits Activation of Coagulation and Fibrinolysis During Human Endotoxemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only